Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenovaTSE:9341 -0.97%77 EV-to-FCF is -127.95 as of Jul. 16, 2026. GuruFocus rates TSE:9341 with a GF Score™ of 77/100 and a GF Value™ of 円1,961.82 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 413 Medical Devices & Instruments companies, Genova ranks worse than 242130.51% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Genova's Enterprise Value is 円6,012 Mil.
Genova's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円-47 Mil. Therefore, Genova's EV-to-FCF for today is -127.95.
The historical rank and industry rank for Genova's EV-to-FCF or its related term are showing as below:
TSE:9341'
s EV-to-FCF Range Over the Past 10 Years
Min: -131.28 Med: 11.03 Max: 51.64
Current: -131.28
During the past 6 years, the highest EV-to-FCF of Genova was 51.64. The lowest was -131.28. And the median was 11.03.
TSE:9341's EV-to-FCF is ranked worse than 100% of 413
companies
in the Medical Devices & Instruments industry
Industry Median: 23.72
vs TSE:9341: -131.28
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-16), Genova's stock price is 円611.00.
Genova's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円15.888. Therefore, Genova's PE Ratio (TTM) for today is 38.46.
Genova (TSE:9341) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Genova's share price for today is 円611.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genova's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円15.888.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Genova EV-to-FCF Related Terms
Genova EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Genova's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Genova's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genova EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Genova's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Genova's EV-to-FCF falls into.
Genova's current Enterprise Value is 円6,012 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genova's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円-47 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genova (TSE:9341) has a EV-to-FCF of -127.95 as of Jul. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Genova and its competitors. According to the industry distribution chart, Genova ranks #999999 out of 413 companies in the Medical Devices & Instruments industry.
Is Genova's EV-to-FCF too high?
Genova's current EV-to-FCF is -127.95. Based on the distribution chart, Genova ranks #999999 out of 413 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Genova has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Genova's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Genova ranks #999999 out of 413 companies for EV-to-FCF. This places Genova in the lower half of its industry. The industry median EV-to-FCF is 23.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.72, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Genova and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genova's current EV-to-FCF is -127.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genova stock overvalued right now?
Based on GuruFocus' analysis, Genova (TSE:9341) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,961.82, compared to a current price of 円611.00 — trading 68.9% below its estimated fair value. The current EV-to-FCF is -127.95. Genova's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Genova (TSE:9341), the current EV-to-FCF is -127.95 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genova (TSE:9341) Overvalued in 2026?
Based on GuruFocus' analysis, Genova stock appears to be undervalued.
The current stock price of 円611.00 is trading 68.9% below its estimated GF Value™ of 円1,961.82.
GuruFocus considers Genova to be Possible Value Trap.
Key valuation signals for TSE:9341:
EV-to-FCF: -127.95
GF Value™: 円1,961.82 vs. price of 円611.00 (68.9% below fair value)
No single metric tells the full story. See the TSE:9341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genova Inc manages operations of the medical information site and sales of automatic reception and payment machines for clinics. The group operates in two reportable segments: Medical Platform Business and the Smart Clinic Project. The majority of its revenue is generated from the Medical Platform Business, which operates an online media site (Medical Dock) that provides preventive information and health knowledge to users (patients) on diseases and symptoms. In addition, it also supports users in finding a family doctor that suits them. The Smart Clinic Business develops and provides services that improve the convenience and efficiency of non-medical procedures at medical institutions.
77GF Score
Get the complete analysis for TSE:9341
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9341 has been successfully added to your 
